| Crystal Structure of AKR1C3 complexed with octyl gallate | | homo-2-mer | 6-320 | 100 | 2×NAP; 1×65D; |
|
| Crystal Structure of AKR1C3 complexed with CAPE | | homo-2-mer | 6-320 | 100 | 2×NAP; 2×QAP; |
|
| Potent and selective Aldo-Keto Reductase 1C3 (AKR1C3) inhibitors based on the benzoisoxazole moiety… | | homo-2-mer | 6-319 | 100 | 2×NAP; 2×CJ2; |
|
| Crystal structure of human 17bet a-hydroxysteroid dehydrogenase type 5 in complexes with PEG and NA… | | monomer | 1-323 | 99.68 | 1×ACT; 1×P6G; 1×NAP; |
|
| Prostaglandin F synthase complexed with NADPH and rutin | | monomer | 5-323 | 99.69 | 1×NDP; 1×RUT; |
|
| Structure of prostaglandin F synthase with prostaglandin D2 | | monomer | 5-323 | 99.69 | 1×NAP; 1×PG2; |
|
| Crystal structures of AKR1C3 binary complex with NADP+ | | monomer | 5-323 | 100 | 1×NAP; 2×EDO; 1×ACT; |
|
| Crystal structure of Aldo-keto reductase 1C3 complexed with compound S07044 | | monomer | 2-320 | 100 | 1×NAP; 1×8FO; |
|
| Crystal structure of prostaglandin F synathase containing bimatoprost | | monomer | 5-323 | 99.69 | 1×NAP; 1×15M; |
|
| Crystal structure of human 17beta-hydroxysteroid dehydrogenase type 5 (AKR1C3) complexed with delta… | | monomer | 5-323 | 99.68 | 1×ACT; 1×NAP; 1×ASD; |
|
| Crystal structure of human 17beta-hydroxysteroid dehydrogenase type 5 in complex with 3-((3,4-dihyd… | | monomer | 5-323 | 100.0 | 1×NAP; 1×0T0; 3×EDO; |
|
| Potent and selective Aldo-Keto Reductase 1C3 (AKR1C3) inhibitors based on the benzoisoxazole moiety… | | monomer | 6-323 | 100 | 1×CVN; 1×CL; 1×NAP; |
|
| Crystal structure of Aldo-Keto Reductase 1C3 (AKR1C3) complexed with inhibitor. | | monomer | 6-323 | 100 | 1×NAP; 1×FFW; 2×EDO; |
|
| W227F active site mutant of AKR1C3 | | monomer | 4-321 | 99.67 | 1×NAP; 2×EDO; 1×ACT; 1×PG4; |
|
| STRUCTURE OF ALDO-KETO REDUCTASE 1C3 (AKR1C3) IN COMPLEX WITH AN INHIBITOR MEDS765 | | monomer | 6-323 | 100 | 1×NAP; 1×A1ICG; 4×EDO; 1×MES; |
|
| Structure of Aldo-Keto Reductase 1C3 (AKR1C3) in complex with an inhibitor M689, with the 3-hydroxy… | | monomer | 6-323 | 100.0 | 1×NAP; 1×YMC; 1×EDO; |
|
| AKR1C3 complexed with new inhibitor with novel scaffold | | monomer | 6-323 | 100 | 1×NAP; 1×9S0; 2×DMF; |
|
| Crystal structure of human 17beta-hydroxysteroid dehydrogenase type 5 in complex with (4-(4-Chlorop… | | monomer | 6-323 | 100.0 | 1×NAP; 1×16J; 1×EDO; |
|
| Crystal structure of human androgenic 17beta-hydroxysteroid dehydrogenase type 5 in complexed with … | | monomer | 5-321 | 99.68 | 1×ACT; 1×E04; 1×NAP; |
|
| AKR1C3 complexed with 3-phenoxybenzoic acid | | monomer | 6-322 | 100.0 | 1×NAP; 1×VJJ; 4×EDO; |
|
| Crystal structure of human 17beta-hydroxysteroid dehydrogenase type 5 in complex with 1-{4-[(2-meth… | | monomer | 5-321 | 100.0 | 1×NAP; 1×10H; |
|
| Crystal structure of human 17beta-hydroxysteroid dehydrogenase type 5 in complex with (R)-1-(naphth… | | monomer | 6-322 | 100.0 | 1×NAP; 1×0SL; 1×EDO; 1×ACT; |
|
| AKR1C3 complex with naproxen | | monomer | 6-322 | 100.0 | 1×NAP; 1×NPS; 4×EDO; |
|
| AKR1C3 complexed with breakdown product of N-(tert-butyl)-2-(2-chloro-4-(((3-mercapto-5-methyl-4H-1… | | monomer | 6-321 | 100 | 1×NAP; 1×YY2; 1×YY1; 2×EDO; |
|
| AKR1C3 complex with indomethacin at pH 7.5 | | monomer | 6-321 | 100.0 | 1×NAP; 1×IMN; 1×EDO; |
|
| AKR1C3 complex with ibuprofen | | monomer | 6-321 | 100.0 | 1×NAP; 1×IZP; 1×EDO; |
|
| Crystal structures of AKR1C3 ternary complex with NADP+ and the chromene derivative 2l | | monomer | 5-320 | 100 | 1×NAP; 1×FJU; |
|
| Crystal structures of AKR1C3 ternary complex with NADP+ and the chromene derivative 2j | | monomer | 5-320 | 100 | 1×NAP; 1×FJR; |
|
| AKR1C3 complex with R-naproxen | | monomer | 6-321 | 100.0 | 1×NAP; 1×NPX; 5×EDO; |
|
| AKR1C3 complex with zomepirac | | monomer | 6-321 | 100.0 | 1×NAP; 1×ZOM; 2×EDO; |
|
| AKR1C3 complex with meclofenamic acid | | monomer | 6-321 | 100.0 | 1×NAP; 1×JMS; 2×EDO; |
|
| Crystal structures of prostaglandin D2 11-ketoreductase (AKR1C3) in complex with the non-steroidal … | | monomer | 6-321 | 100 | 1×ACT; 1×NAP; 1×MPD; |
|
| AKR1C3 complexed with mefenamic acid | | monomer | 6-321 | 100.0 | 1×NAP; 1×ID8; 4×EDO; |
|
| AKR1C3 complex with flurbiprofen | | monomer | 6-321 | 100.0 | 1×NAP; 1×FLR; 1×EDO; |
|
| AKR1C3 complex with sulindac | | monomer | 6-321 | 100.0 | 1×NAP; 1×SUZ; 2×EDO; |
|
| Crystal structure of Aldo-keto reductase 1C3 complexed with compound S0703 | | monomer | 5-320 | 100 | 1×NAP; 1×JTN; |
|
| 17beta-HSD5 in complex with 4-nitro-2-({4-[3-(trifluoromethyl)phenyl]piperazin-1-yl}methyl)phenol | | monomer | 6-321 | 100.0 | 1×NAP; 1×WDV; |
|
| Crystal structures of prostaglandin D2 11-ketoreductase (AKR1C3) in complex with the non-steroidal … | | monomer | 6-320 | 100 | 1×ACT; 1×NAP; 1×MPD; |
|
| 17beta-HSD5 in complex with 2-nitro-5-(phenylsulfonyl)phenol | | monomer | 6-320 | 100 | 1×NAP; 1×WDT; |
|
| 17beta-HSD5 in complex with 3-pentyl-2-[(pyridin-2-ylmethyl)sulfanyl]-7-(pyrrolidin-1-ylcarbonyl)qu… | | monomer | 6-320 | 100 | 1×NAP; 1×WDS; |
|
| Crystal structures of prostaglandin D2 11-ketoreductase in complex with the non-steroidal anti-infl… | | monomer | 6-320 | 100 | 1×NAP; 1×IMN; 1×DMS; 1×UNX; |
|
| 17beta-HSD5 in complex with 4-chloro-N-(4-chlorobenzyl)-5-nitro-1H-pyrazole-3-carboxamide | | monomer | 6-320 | 100 | 1×NAP; 1×WDU; |
|
| Crystal structures of prostaglandin D2 11-ketoreductase in complex with the non-steroidal anti-infl… | | monomer | 6-320 | 100 | 1×NAP; 2×FLF; 1×DMS; |
|
| Crystal structure of human 17beta-hydroxysteroid dehydrogenase type 5 (AKR1C3) in complex with NADP… | | monomer | 6-320 | 100 | 1×NAP; 2×511; |
|
| Crystal structure of human 17beta-hydroxysteroid dehydrogenase type 5 (AKR1C3) in complex with NADP… | | monomer | 6-320 | 100 | 1×NAP; 2×0HV; |
|
| Crystal structure of AKR1C3 complexed with glicazide | | monomer | 6-320 | 100 | 1×NAP; 1×GCZ; |
|
| Crystal structure of human 17beta-hydroxysteroid dehydrogenase type 5 in complex with 3-((3,4-dihyd… | | monomer | 6-320 | 100 | 1×NAP; 1×0SZ; 6×EDO; |
|
| Crystal structure of Aldo-keto reductase 1C3 complexed with compound S07054 | | monomer | 6-320 | 100.0 | 1×NAP; 1×8IT; |
|
| Crystal structure of AKR1C3 complexed with glibenclamide | | monomer | 6-320 | 100 | 1×NAP; 1×GBM; |
|
| Crystal structure of AKR1C3 complexed with glimepiride | | monomer | 6-320 | 100 | 1×GMR; 1×NAP; |
|
| Crystal structure of human 17beta-hydroxysteroid dehydrogenase type 5 (AKR1C3) in complex with NADP… | | monomer | 6-320 | 100 | 1×NAP; 1×BT9; |
|
| Crystal structure of Aldo-keto reductase 1C3 complexed with compound S07045 | | monomer | 6-320 | 100 | 1×NAP; 1×8IH; |
|
| Structure of AKR1C3 in complex with a bile acid fused tetrazole inhibitor | | monomer | 6-319 | 100 | 1×NAP; 1×QBO; 4×NA; |
|
| AKR1C3 complex with indomethacin at pH 6.8 | | monomer | 6-319 | 100.0 | 1×NAP; 1×IMN; 1×DMS; 2×EDO; |
|
| Crystal structure of AKR1C3 in complex with DFV | | monomer | 6-319 | 100 | 1×NAP; 1×DFV; |
|
| Crystal structure of Aldo-keto reductase 1C3 complexed with compound 25 | | monomer | 6-319 | 100 | 1×NAP; 1×4ZI; |
|
| Crystal structure of Aldo-keto reductase 1C3 complexed with compound 28 | | monomer | 6-319 | 100 | 1×NAP; 1×4R6; |
|
| Crystal structure of Aldo-keto reductase 1C3 complexed with compound 24 | | monomer | 6-319 | 100 | 1×NAP; 1×4IV; |
|
| 17beta-HSD5 in complex with [4-(2-hydroxyethyl)piperidin-1-yl](5-methyl-1H-indol-2-yl)methanone | | monomer | 6-311 | 100.0 | 1×NAP; 1×WDX; |
|
| 17beta-HSD5 in complex with 3,6-dihydropyridin-1(2H)-yl(5-methyl-1H-indol-2-yl)methanone | | monomer | 6-306 | 100.0 | 1×NAP; 1×WDW; |
|